FRCD

Methyldopa or alpha-methyldopa (brand names Aldomet, Apo-Methyldopa, Dopamet, Novomedopa) is a centrally-acting adrenergic antihypertensive medication. Its use is now deprecated following introduction of alternative safer classes of agents. However it continues to have a role in otherwise difficult to treat hypertension and gestational hypertension (formerly known as pregnancy-induced hypertension). Methyldopa is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Only methyldopa, the <i>L</i>-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. In man the antihypertensive activity appears to be due solely to the L-isomer. About twice the dose of the racemate (DL-alpha-methyldopa) is required for equal antihypertensive effect. Methyldopa has no direct effect on cardiac function and usually does not reduce glomerular filtration rate, renal blood flow, or filtration fraction. Cardiac output usually is maintained without cardiac acceleration. In some patients the heart rate is slowed. Normal or elevated plasma renin activity may decrease in the course of methyldopa therapy. Methyldopa reduces both supine and standing blood pressure. Methyldopa usually produces highly effective lowering of the supine pressure with infrequent symptomatic postural hypotension. Exercise hypotension and diurnal blood pressure variations rarely occur. Methyldopa, in its active metabolite form, is a central alpha-2 receptor agonist. Using methyldopa leads to alpha-2 receptor-negative feedback to sympathetic nervous system (SNS) (centrally and peripherally), allowing peripheral sympathetic nervous system tone to decrease. Such activity leads to a decrease in total peripheral resistance (TPR) and cardiac output. When introduced it was a mainstay of antihypertensive therapy, but its use has declined, with increased use of other safer classes of agents. One of its important present-day uses is in the management of pregnancy-induced hypertension, as it is relatively safe in pregnancy compared to other antihypertensive drugs (Wikipedia).

(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

CJCSPKMFHVPWAR-JTQLQIEISA-N

InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1

CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N

C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N

        
            l-alpha-Methyldopa
        
            methyldopa
        
            555-30-6
        
            Alphamethyldopa
        
            Aldomet
        
            Alpha medopa
        
            Dopamet
        
            alpha-Methyl dopa
        
            Baypresol
        
            Hyperpax
        

                

                  
                    Predicted: Animal Toxin
                  

                
        

• Hydrocarbon derivatives
• Organic oxides
• Carbonyl compounds
• Organopnictogen compounds
• 1-hydroxy-4-unsubstituted benzenoids
• 1-hydroxy-2-unsubstituted benzenoids
• Monocarboxylic acids and derivatives
• Carboxylic acids
• Monoalkylamines
• Amino acids
• Aralkylamines
• Amphetamines and derivatives
• Phenylpropanes
• Catechols